Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terrence P Tougas

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
AAPS Pharmscitech|April 13, 2016
A Comparison of the Performance of Efficient Data Analysis Versus Fine Particle Dose as Metrics for the Quality Control of Aerodynamic Particle Size Distributions of Orally Inhaled PharmaceuticalsTerrence P Tougas, Adrian P Goodey, Gareth Hardwell, et al.
AAPS Pharmscitech|February 3, 2011
Product lifecycle approach to cascade impaction measurementsTerrence P Tougas, Dave Christopher, Jolyon Mitchell, et al.
AAPS Pharmscitech|November 3, 2009
Improved quality control metrics for cascade impaction measurements of orally inhaled drug products (OIPs)Terrence P Tougas, David Christopher, Jolyon P Mitchell, et al.
AAPS Pharmscitech|June 1, 2019
Determination of Passive Dry Powder Inhaler Aerodynamic Particle Size Distribution by Multi-Stage Cascade Impactor: International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) Recommendations to Support Both Product Quality Control and Clinical ProgramsJolyon P Mitchell, Stephen W Stein, William Doub, et al.
AAPS Pharmscitech|June 8, 2017
Discriminating Ability of Abbreviated Impactor Measurement Approach (AIM) to Detect Changes in Mass Median Aerodynamic Diameter (MMAD) of an Albuterol/Salbutamol pMDI AerosolJ David Christopher, Rajni B Patel, Jolyon P Mitchell, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
AAPS Pharmscitech|April 13, 2016
A Comparison of the Performance of Efficient Data Analysis Versus Fine Particle Dose as Metrics for the Quality Control of Aerodynamic Particle Size Distributions of Orally Inhaled PharmaceuticalsTerrence P Tougas, Adrian P Goodey, Gareth Hardwell, et al.
AAPS Pharmscitech|February 3, 2011
Product lifecycle approach to cascade impaction measurementsTerrence P Tougas, Dave Christopher, Jolyon Mitchell, et al.
AAPS Pharmscitech|November 3, 2009
Improved quality control metrics for cascade impaction measurements of orally inhaled drug products (OIPs)Terrence P Tougas, David Christopher, Jolyon P Mitchell, et al.
AAPS Pharmscitech|June 1, 2019
Determination of Passive Dry Powder Inhaler Aerodynamic Particle Size Distribution by Multi-Stage Cascade Impactor: International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) Recommendations to Support Both Product Quality Control and Clinical ProgramsJolyon P Mitchell, Stephen W Stein, William Doub, et al.
AAPS Pharmscitech|June 8, 2017
Discriminating Ability of Abbreviated Impactor Measurement Approach (AIM) to Detect Changes in Mass Median Aerodynamic Diameter (MMAD) of an Albuterol/Salbutamol pMDI AerosolJ David Christopher, Rajni B Patel, Jolyon P Mitchell, et al.
Pageof 1